Investor insights
Sectors invested in
Biotechnology1
Health Care1
Oncology and Network Biology1
Pharmaceutical1
Funding rounds participated in
$28M sweet spot round size
Most of their 1 investments are in rounds between $28M and $28M
Basic info
Industry
pharmaceutical manufacturing
Sectors
Rare diseases
Biotechnology
Preeclampsia
Therapeutics
Antithrombin
Date founded
1993
Investments made
M
Merrimack Pharmaceuticals raised $28M on May 5, 2004
Investors: Wharton Capital Partners LTD and rEVO Biologics